AAA PatientCONNECT

Advanced Accelerator Applications (AAA), a Novartis Company, offers the AAA PatientCONNECT program to deliver assistance to eligible patients who have been prescribed Pluvicto (Table).

AAA PatientCONNECT

Enrollment in AAA PatientCONNECT activates a continuum of support for your patients that may include benefits verification/prior authorization information, product ordering, reimbursement information, and financial assistance options.

AAA PatientCONNECT Copay Assistance Program

Patients may be eligible for the Copay Assistance Program if they:

• Have commercial insurance coverage
• Do not have Medicare, Medicaid, or any other federal or state healthcare program
• Are aged ≥18 years
• Are a permanent resident of the United States, the commonwealth of Puerto Rico, or the US Virgin Islands
• Have a prescription for Pluvicto for an FDA-approved indication.

The Novartis Patient Assistance Foundation

The Novartis Patient Assistance Foundation (NPAF) is committed to providing access to Novartis medications for those most in need. Patients may be eligible for NPAF assistance if they:

• Reside in the United States or a US territory
• Meet certain income requirements
• Have limited or no private or public prescription coverage.

To enroll your patient in AAA PatientCONNECT, including the Copay Assistance Program or the Novartis Patient Assistance Foundation, complete the application online.

TABLE AAA Oncology Drug